MAR-COF CG
- Product NDC
- 0682-0475
- 11-digit product format
- 006820475
- Labeler code
- 0682
- Product ID
- 0682-0475_13b802bb-b30a-864a-e063-6394a90a4dfd
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- CODEINE PHOSPHATE and GUAIFENESIN
- Dosage form
- SYRUP
- Route
- ORAL
- Labeler
- Marnel Pharmaceuticals, LLC
- Application
- M012
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2008-12-01
- Substance
- CODEINE PHOSPHATE; GUAIFENESIN
- Active strength
- 7.5; 225 mg/5mL; mg/5mL
- Pharmacologic classes
- Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Full Opioid Agonists [MoA], Increased Respiratory Secretions [PE], Opioid Agonist [EPC]
- DEA schedule
- CV
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded product | product | 1332a3947898… | d4bfe170f9cd… | |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded package | package | 0682-0475-16 | 1332a3947898… | d4bfe170f9cd… |
| 2022-08-30 03:57 UTC · source 2022-08-29 | excluded product | product | fb8cb913e6d1… | eb8c232b6be0… | |
| 2022-08-30 03:57 UTC · source 2022-08-29 | excluded package | package | 0682-0475-16 | fb8cb913e6d1… | eb8c232b6be0… |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded product | product | 86f5da6cb304… | a595104c45d7… | |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded package | package | 0682-0475-16 | 86f5da6cb304… | a595104c45d7… |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded product | product | bd6a592717d7… | 303034d00443… | |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded package | package | 0682-0475-16 | bd6a592717d7… | 303034d00443… |
| 2021-12-27 23:28 UTC · source 2021-12-27 | excluded product | product | 8dfbde2a14a4… | c9ff85d89658… | |
| 2021-12-27 23:28 UTC · source 2021-12-27 | excluded package | package | 0682-0475-16 | 8dfbde2a14a4… | c9ff85d89658… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- MAR-COF CG
- Brand name suffix
- Expectorant
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| CODEINE PHOSPHATE | 7.5 mg/5mL |
| GUAIFENESIN | 225 mg/5mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| GSL05Y1MN6 | Internal UNII lookup |
| 495W7451VQ | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 60a41229-b125-43d8-b2b4-0bf40feed764 | Available on FDA.report |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
| Effective | Related label |
|---|---|
| 2024-03-15 | MAR-COF ® CG Expectorant |
| 2024-01-30 | MAR-COF ® CG Expectorant |
| 2022-10-17 | MAR-COF ® CG Expectorant |
| 2021-07-23 | MAR-COF ® CG Expectorant |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0682-0475-16 | MAR-COF CGExpectorant | 473 mL in 1 BOTTLE | SYRUP | 473 | 5 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0682-0475-16 | ML - Milliliter | 0682-0475 | 96e067ee-d836-4dbd-aa6a-1ca12507d95b | 1 | 2014-02-04 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Allergy Multi Symptom | ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, AND PHENYLEPHRINE HYDROCHLORIDE | CHAIN DRUG MARKETING ASSOCIATION, INC. | d49b42ad-0ae0-48c9-adba-5fc2ced97764 | 2024-08-12 | Warnings | M012 |
| RYMED | DEXCHLORPHENIRAMINE MALEATE AND PHENYLEPHRINE HYDROCHLORIDE | EDWARDS PHARMACEUTICALS, INC. | c1d6e914-74cc-4cdf-9587-7eaaa4a386e5 | 2024-08-12 | Warnings | M012 |
| WesTussin DM NF | WESTUSSIN DM NF | Westminster Pharmaceuticals, LLC | 4e0f9f97-a31c-41ac-9d6c-d81efd20fcef | 2024-08-08 | Warnings | M012 |
| Mucus Relief Sinus Severe Congestion and Pain | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | CHAIN DRUG MARKETING ASSOCIATION, INC. | 2f2a2864-af11-4240-bdad-a54aca58d01b | 2024-08-07 | Warnings | M012 |
| Cold plus Flu Congestion Severe | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | CHAIN DRUG MARKETING ASSOCIATION, INC. | 0199aea2-a9c1-4c9d-8786-28b9dadc832e | 2024-08-07 | Warnings | M012 |
| Mucus Relief Cold Flu and Sore Throat | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | CHAIN DRUG MARKETING ASSOCIATION, INC. | 32d1ce6e-2617-4b50-a9e6-2e1941465dff | 2024-08-07 | Warnings | M012 |
| Sinus Severe | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | CHAIN DRUG MARKETING ASSOCIATION, INC. | 07362db5-a372-4463-af8b-06e8783ca865 | 2024-08-07 | Warnings | M012 |
| Head Congestion plus Flu Severe PE | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | CHAIN DRUG MARKETING ASSOCIATION, INC. | 1fb11d90-48bf-4baa-9b3a-5d64d81e3a06 | 2024-08-07 | Warnings | M012 |
| Mucus Relief Sinus Pressure Pain and Cough | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | CHAIN DRUG MARKETING ASSOCIATION, INC. | 574774b2-9813-4799-9cd4-27e296dd8584 | 2024-08-07 | Warnings | M012 |
| Cold Max Day and NIght | ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, AND PHENYLEPHRINE HYDROCHLORIDE | CHAIN DRUG MARKETING ASSOCIATION, INC. | a92bcefb-ba29-4b3f-a60b-b4476ca8cf04 | 2024-08-07 | Warnings | M012 |
| Sinus plus Headache | ACETAMINOPHEN AND PHENYLEPHRINE HYDROCHLORIDE | CHAIN DRUG MARKETING ASSOCIATION, INC. | 778f1f5a-fd04-456f-90d0-998b93e774a5 | 2024-08-07 | Warnings | M012 |
| Head Congestion plus Mucus PE | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | CHAIN DRUG MARKETING ASSOCIATION, INC. | 990f3232-bc75-45cf-8a50-cd7861d83f98 | 2024-08-07 | Warnings | M012 |
| Mucus Relief Cold and Flu All in One | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | CHAIN DRUG MARKETING ASSOCIATION, INC. | 0f5f25c6-7389-4285-b8d5-463cb7b6fcc4 | 2024-08-07 | Warnings | M012 |
| Nighttime Cold and Flu | ACETAMINOPHEN DEXTROMETHORPHAN HBR DOXYLAMINE SUCCINATE | Care One (Retail Business Services, LLC.) | a9a5b39d-b4c8-414e-8fe7-4c0601f75197 | 2024-08-05 | Warnings | M012 |
| Diphenhydramine HCl | DIPHENHYDRAMINE HYDROCHLORIDE | American Health Packaging | b94feeb6-f33f-410d-a9b0-776b1ccf34a9 | 2024-08-04 | Warnings | M012 |
| Diphenhydramine HCl | DIPHENHYDRAMINE HYDROCHLORIDE | American Health Packaging | 4cd8aee3-5522-434b-a1b1-9591bed3e9a6 | 2024-08-04 | Warnings | M012 |
| Guaifenesin DM | GUAIFENESIN AND DEXTROMETHORPHAN | American Health Packaging | 8632a655-7f5b-450f-95fa-62478a174e9c | 2024-08-04 | Warnings | M012 |
| Guaifenesin DM | GUAIFENESIN AND DEXTROMETHORPHAN | American Health Packaging | 990906b3-c566-4f35-923c-060202ba48e0 | 2024-08-04 | Warnings | M012 |
| Honey Lemon Flavor Cough Drops | HONEY LEMON FLAVOR MENTHOL | WHOLE FOODS MARKET, INC. | 1eb7abdc-061f-0e18-e063-6294a90a3a65 | 2024-08-02 | Warnings | M012 |
| Herbal Flavor Menthol Cough Drops | HERBAL FLAVOR MENTHOL COUGH DROPS | WHOLE FOODS MARKET, INC. | 1eb848b6-3dec-5b5f-e063-6394a90aea14 | 2024-08-02 | Warnings | M012 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 995441 | codeine phosphate 7.5 MG / guaiFENesin 225 MG in 5 mL Oral Solution | PSN | 60a41229-b125-43d8-b2b4-0bf40feed764 | 5 |
| 995443 | MAR-COF CG 7.5 MG / 225 MG in 5 mL Oral Solution | PSN | 60a41229-b125-43d8-b2b4-0bf40feed764 | 5 |
| 995443 | codeine phosphate 1.5 MG/ML / guaifenesin 45 MG/ML Oral Solution [Mar-cof CG] | SBD | 60a41229-b125-43d8-b2b4-0bf40feed764 | 5 |
| 995441 | codeine phosphate 1.5 MG/ML / guaifenesin 45 MG/ML Oral Solution | SCD | 60a41229-b125-43d8-b2b4-0bf40feed764 | 5 |
| 995441 | codeine phosphate 7.5 MG / guaifenesin 225 MG per 5 ML Oral Solution | SY | 60a41229-b125-43d8-b2b4-0bf40feed764 | 5 |
| 995443 | Mar-cof CG (codeine phosphate 7.5MG / guaifenesin 225 MG) per 5 ML Oral Solution | SY | 60a41229-b125-43d8-b2b4-0bf40feed764 | 5 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 0682-0475-16 | 00682047516 | 473 mL in 1 BOTTLE (0682-0475-16) | 473 ml | 2008-12-01 | 0000-00-00 | No | No | Current |